Historic Victory as People With Diabetes Win Access to Life-Changing Technology, But Almost Half Don’t Understand the Benefits1-2
Dexcom’s research follows the new Technology Appraisal (TA) from NICE which provides detailed guidance for hybrid closed loop systems usage.
- Dexcom’s research follows the new Technology Appraisal (TA) from NICE which provides detailed guidance for hybrid closed loop systems usage.
- The new TA impacts an eligible population of over 150,000 people living with Type 1 diabetes in England, providing access to HCL systems3.
- HCL systems powered by Dexcom real-time CGM have been proven to significantly improve outcomes – giving people with diabetes more confidence in their diabetes management4-6, 8-11.
- The research was conducted by Censuswide with 251 UK healthcare professionals (aged 18+) involved in the care of people with T1 diabetes between 10.10.2023 - 18.10.2023.